Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CBX3 pseudogene 10 (CBX3P10) is a DNA sequence annotated as a pseudogene, meaning it is a non-functional segment of DNA that resembles the functional CBX3 gene but cannot produce a working protein due to mutations or deletions[5]. Pseudogenes do not encode active proteins and are generally not considered therapeutic targets. While the functional gene CBX3 (chromobox protein homolog 3, also known as HP1 gamma) is involved in chromatin structure, gene silencing, and is implicated in cancer and cellular processes[1][3][4][6], CBX3P10 itself does not share these functional roles and is not targeted by drugs. Summary: All available evidence indicates CBX3P10 is a pseudogene, not an enzyme, receptor, transporter, or any other class of therapeutic target. Its identification in databases serves a genomic annotation purpose and does not implicate it in therapeutic or pathophysiological processes[5]. If you intended to inquire about the functional CBX3 rather than the pseudogene (CBX3P10), please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CBX3 pseudogene 10 (CBX3P10).